Bittenbinder, M.A.; Zdenek, C.N.; Op den Brouw, B.; Youngman, N.J.; Dobson, J.S.; Naude, A.; Vonk, F.J.; Fry, B.G.
Coagulotoxic Cobras: Clinical Implications of Strong Anticoagulant Actions of African Spitting Naja Venoms That Are Not Neutralised by Antivenom but Are by LY315920 (Varespladib). Toxins 2018, 10, 516.
https://doi.org/10.3390/toxins10120516
AMA Style
Bittenbinder MA, Zdenek CN, Op den Brouw B, Youngman NJ, Dobson JS, Naude A, Vonk FJ, Fry BG.
Coagulotoxic Cobras: Clinical Implications of Strong Anticoagulant Actions of African Spitting Naja Venoms That Are Not Neutralised by Antivenom but Are by LY315920 (Varespladib). Toxins. 2018; 10(12):516.
https://doi.org/10.3390/toxins10120516
Chicago/Turabian Style
Bittenbinder, Mátyás A., Christina N. Zdenek, Bianca Op den Brouw, Nicholas J. Youngman, James S. Dobson, Arno Naude, Freek J. Vonk, and Bryan G. Fry.
2018. "Coagulotoxic Cobras: Clinical Implications of Strong Anticoagulant Actions of African Spitting Naja Venoms That Are Not Neutralised by Antivenom but Are by LY315920 (Varespladib)" Toxins 10, no. 12: 516.
https://doi.org/10.3390/toxins10120516
APA Style
Bittenbinder, M. A., Zdenek, C. N., Op den Brouw, B., Youngman, N. J., Dobson, J. S., Naude, A., Vonk, F. J., & Fry, B. G.
(2018). Coagulotoxic Cobras: Clinical Implications of Strong Anticoagulant Actions of African Spitting Naja Venoms That Are Not Neutralised by Antivenom but Are by LY315920 (Varespladib). Toxins, 10(12), 516.
https://doi.org/10.3390/toxins10120516